Stock listing
TSX:EPRX Eupraxia Pharmaceuticals, Inc. Stock
Home listing (TSX) of Eupraxia Pharmaceuticals, Inc.
Follow Eupraxia Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · TSX:EPRX
$9.37 CAD -0.15 (-1.6%)
Close on Nov 2, 2026
- Day range
- $9.28 – $9.64 CADNov 2, 2026
- Volume
- 48,392 sharesNov 2, 2026
- Market cap
- $619.1M CADAt the close on Nov 2, 2026 · price × 66.07M shares outstanding
- 52-week range
- $7.35 – $13.08 CADLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $863,760 CADMedian day 72,100 shares · last 3 months, Aug 4, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSX:EPRX · Home | $9.37 CAD | -0.15 (-1.6%) | 48,392 | $9.44 | $9.64 | $9.28 | $9.52 | Close on Nov 2, 2026 |
| NASDAQ:EPRX | $7.08 USD | +0.21 (+3.1%) | 484,966 | $6.90 | $7.16 | $6.64 | $6.87 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 2, 2026 · TSX:EPRX · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $9.37 | -0.15 | -1.6% | $9.44 | $9.64 | $9.28 | 48,392 | |
| $9.52 | -0.62 | -6.1% | $10.11 | $10.11 | $8.94 | 112,939 | |
| $10.14 | -0.14 | -1.4% | $10.18 | $10.46 | $9.935 | 83,427 | |
| $10.28 | +0.30 | +3.0% | $9.82 | $10.38 | $9.71 | 87,895 | |
| $9.98 | +0.43 | +4.5% | $9.55 | $10.01 | $9.35 | 110,820 | |
| $9.55 | -0.02 | -0.2% | $9.58 | $9.80 | $9.44 | 52,738 | |
| $9.57 | -1.08 | -10.1% | $10.50 | $10.50 | $9.37 | 82,029 | |
| $10.65 | -0.15 | -1.4% | $10.78 | $11.08 | $10.57 | 135,900 | |
| $10.80 | +0.08 | +0.7% | $10.72 | $10.93 | $10.63 | 115,600 | |
| $10.72 | +0.89 | +9.1% | $9.71 | $10.90 | $9.54 | 175,800 | |
| $9.83 | +0.48 | +5.1% | $9.51 | $9.91 | $9.51 | 62,800 | |
| $9.35 | -0.28 | -2.9% | $9.60 | $9.69 | $9.28 | 66,500 | |
| $9.63 | +0.27 | +2.9% | $9.60 | $9.68 | $9.24 | 74,900 | |
| $9.36 | -0.23 | -2.4% | $9.50 | $9.68 | $9.20 | 67,200 | |
| $9.59 | -1.04 | -9.8% | $10.40 | $10.47 | $9.43 | 157,300 | |
| $10.63 | -0.10 | -0.9% | $10.72 | $10.99 | $10.38 | 76,500 | |
| $10.73 | -0.30 | -2.7% | $11.00 | $11.00 | $10.44 | 37,400 | |
| $11.03 | +0.02 | +0.2% | $10.78 | $11.23 | $10.65 | 73,200 | |
| $11.01 | +0.02 | +0.2% | $10.87 | $11.43 | $10.87 | 94,400 | |
| $10.99 | +0.67 | +6.5% | $10.50 | $11.28 | $10.29 | 117,000 | |
| $10.32 | -0.87 | -7.8% | $11.36 | $11.41 | $10.26 | 171,000 | |
| $11.19 | -1.80 | -13.9% | $12.81 | $12.94 | $10.93 | 231,900 | |
| $12.99 | +1.13 | +9.5% | $11.84 | $13.08 | $11.50 | 214,300 | |
| $11.86 | +0.21 | +1.8% | $11.74 | $11.98 | $11.53 | 72,100 | |
| $11.65 | +0.34 | +3.0% | $11.10 | $11.65 | $11.10 | 67,600 | |
| $11.31 | -0.19 | -1.7% | $11.44 | $11.67 | $11.11 | 54,900 | |
| $11.50 | +0.05 | +0.4% | $11.35 | $11.97 | $11.14 | 53,400 | |
| $11.45 | -0.63 | -5.2% | $11.99 | $12.05 | $11.26 | 107,200 | |
| $12.08 | -0.02 | -0.2% | $12.12 | $12.22 | $11.82 | 78,000 | |
| $12.10 | +0.13 | +1.1% | $12.19 | $12.29 | $11.95 | 72,800 | |
| $11.97 | +0.27 | +2.3% | $11.69 | $12.15 | $11.69 | 165,600 | |
| $11.70 | +0.43 | +3.8% | $11.50 | $11.77 | $11.45 | 74,100 | |
| $11.27 | +0.07 | +0.6% | $11.25 | $11.39 | $11.17 | 58,100 | |
| $11.20 | -0.01 | -0.1% | $11.35 | $11.35 | $11.06 | 55,800 | |
| $11.21 | -0.48 | -4.1% | $11.66 | $11.71 | $11.13 | 60,500 | |
| $11.69 | +0.61 | +5.5% | $11.27 | $11.79 | $11.26 | 132,600 | |
| $11.08 | -0.01 | -0.1% | $11.21 | $11.48 | $11.05 | 42,100 | |
| $11.09 | -0.295 | -2.6% | $11.33 | $11.52 | $11.05 | 24,900 | |
| $11.39 | -0.255 | -2.2% | $11.53 | $11.82 | $11.32 | 74,400 | |
| $11.64 | +1.28 | +12.4% | $10.35 | $11.64 | $10.26 | 102,700 | |
| $10.36 | +0.06 | +0.6% | $10.34 | $10.52 | $10.12 | 73,000 | |
| $10.30 | +1.51 | +17.2% | $8.81 | $10.33 | $8.81 | 127,800 | |
| $8.79 | -0.18 | -2.0% | $8.86 | $9.02 | $8.79 | 33,000 | |
| $8.97 | -0.31 | -3.3% | $9.95 | $9.95 | $8.78 | 53,100 | |
| $9.28 | -0.89 | -8.8% | $10.16 | $10.16 | $9.28 | 29,100 | |
| $10.17 | -0.11 | -1.1% | $10.36 | $10.36 | $10.13 | 34,900 | |
| $10.28 | +0.08 | +0.8% | $10.15 | $10.32 | $10.04 | 32,700 | |
| $10.20 | +0.15 | +1.5% | $9.94 | $10.31 | $9.93 | 83,000 | |
| $10.05 | +0.75 | +8.1% | $9.48 | $10.20 | $9.20 | 195,600 | |
| $9.30 | -0.02 | -0.2% | $9.33 | $9.435 | $9.17 | 28,300 | |
| $9.32 | -0.40 | -4.1% | $9.58 | $9.58 | $9.21 | 34,000 | |
| $9.72 | +0.22 | +2.3% | $9.65 | $9.73 | $9.38 | 157,600 | |
| $9.50 | 0.00 | 0.0% | $9.40 | $9.52 | $9.30 | 74,700 | |
| $9.50 | +0.19 | +2.0% | $9.92 | $9.92 | $9.27 | 40,000 | |
| $9.31 | -0.01 | -0.1% | $9.30 | $9.31 | $8.95 | 24,500 | |
| $9.32 | +0.23 | +2.5% | $9.39 | $9.50 | $9.10 | 53,300 | |
| $9.09 | -0.26 | -2.8% | $9.36 | $9.445 | $8.91 | 69,200 | |
| $9.35 | -0.02 | -0.2% | $9.54 | $9.54 | $9.27 | 23,300 | |
| $9.37 | -0.09 | -1.0% | $9.54 | $9.54 | $9.29 | 29,900 | |
| $9.46 | +0.13 | +1.4% | $9.33 | $9.54 | $9.17 | 36,200 | |
| $9.33 | +0.26 | +2.9% | $9.04 | $9.42 | $8.94 | 63,100 | |
| $9.07 | -0.05 | -0.5% | $9.21 | $9.40 | $9.05 | 32,900 | |
| $9.12 | +0.14 | +1.6% | $8.91 | $9.27 | $8.91 | 66,800 |
- Ticker
- TSX:EPRX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TSX
- Currency
- CAD
What changed lately
Latest news release · Oct 22, 2026
Eupraxia Pharmaceuticals to Participate at Upcoming Conferences and Host a Virtual Analyst Day
Latest deck · Oct 17, 2026
United European Gastroenterology Week 2026
Conference · 15 slides
Latest news
Eupraxia Pharmaceuticals to Participate at Upcoming Conferences and Host a Virtual Analyst Day
Oct 22, 2026
Closed $10.65 (-1.4%) on Oct 22, 2026
Eupraxia Pharmaceuticals Reaches its Enrollment Target for the RESOLVE Trial Investigating EP-104GI for the Treatment of Eosinophilic Esophagitis
Oct 15, 2026
Closed $9.63 (+2.9%) on Oct 15, 2026
Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences
Oct 9, 2026
Closed $10.63 (-0.9%) on Oct 9, 2026
Eupraxia Pharmaceuticals Reports 52-Week Data from the Highest Dose Cohort of EP-104GI in its Ongoing Phase 1b/2a RESOLVE Trial for the Treatment of Eosinophilic Esophagitis
Sep 30, 2026
Closed $12.99 (+9.5%) on Sep 30, 2026
Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences
Sep 8, 2026
Closed $11.39 (-2.2%) on Sep 8, 2026
Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis Patients
Aug 13, 2026
Closed $9.32 (+2.5%) on Aug 13, 2026
Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results
Aug 11, 2026
Closed $9.09 (-2.8%) on Aug 12, 2026
Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth
Jul 13, 2026
Closed $8.91 (-2.0%) on Jul 14, 2026
Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization
Jul 7, 2026
Closed $9.48 (+2.2%) on Jul 7, 2026
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
Jun 19, 2026
Closed $9.38 (+3.5%) on Jun 22, 2026
Decks
United European Gastroenterology Week 2026
Conference · 15 slides · Oct 17, 2026
Investor Presentation (July 2026)
Investor deck · 41 slides · July 2026
World Congress of Gastroenterology @ Australian Gastroenterology Week 2025
Conference · 8 slides · September 2025
Eupraxia Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 28 in the last 12 months · 129 in all · newest Oct 22, 2026 · oldest 2021
- Decks
- 3 decks · latest Oct 17, 2026
Where Eupraxia Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:EPRX · Home listing · This page | TSX | Canada | CAD |
| NASDAQ:EPRX | NASDAQ | United States | USD |
| Cboe Canada:EPRX | Cboe Canada | Canada | CAD |
| Lang & Schwarz:A3EGRS | Lang & Schwarz | Germany | EUR |
| LS Exchange:A3EGRS | LS Exchange | Germany | EUR |
| BOATS:EPRX | BOATS | United States | USD |
| Frankfurt:X43 | Frankfurt | Germany | EUR |
| Stuttgart:X43 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Eupraxia Pharmaceuticals, Inc.